Rora Regulates Hematopoietic Stem Cell Phenotypes And Progression Of Chronic Myelogenous Leukemia
Our bodies rely on special cells called hematopoietic stem cells, or HSCs, which are like master cells in our bone marrow that produce all types of blood cells throughout our lives. As we age, these HSCs can become less effective, leading to various blood-related issues. A recent study has shed light on a key player in this process: a protein known as RORA.
Scientists discovered that RORA acts as a vital regulator, helping to keep HSCs healthy and functional. When RORA was removed from these stem cells, they showed signs of aging and were less able to regenerate blood cells. This suggests that RORA plays a crucial role in preventing the natural decline of our blood-forming system over time.
Beyond its role in healthy aging, the research also uncovered RORA’s significant impact on a serious blood cancer called Chronic Myelogenous Leukemia (CML). CML is characterized by the uncontrolled growth of abnormal white blood cells, originating from what are known as leukemia stem cells (LSCs). The study found that a lack of RORA hindered the multiplication of these leukemia stem cells and, importantly, prevented the development of CML.
These findings establish RORA as a critical regulator in maintaining HSC function and provide insights into its therapeutic potential in hematological disorders. Understanding how RORA works could pave the way for new therapies to combat aging-related blood problems and improve treatments for blood cancers.
Source: link to paper